Bonumose

Bonumose is an early-stage food ingredient manufacturer specializing in the affordable production of delicious, good-for-you sugars such as tagatose and allulose. Founded in 2016, the company aims to provide healthy ingredients that meet consumer demand for flavorful products without compromising their health or budget. The innovative, enzymatic technology discovered by Dr. Daniel Wichelecki forms the foundation of Bonumose's platform, enabling the commercial-scale production of rare sugars that are packed with health benefits. Despite being less abundant in nature, rare sugars offer advantages such as promoting healthy teeth, glycemic control, and improved gut health. Operating in the Food and Beverage industry, Bonumose is headquartered in the United States. The company recently secured a significant $34.68M in a Funding Round investment on 11 October 2023, showcasing robust investor interest in its innovative approach to producing healthier sugars for the mass market. Moving forward, the company's focus on providing affordable, naturally-occurring ingredients with widespread health benefits positions it well in the evolving consumer preferences for healthier food choices.